This content is machine translated Respiratory syncytial virus (RSV) New vaccine candidate receives CHMP recommendation The positive opinion of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) is based on Phase III study data showing statistically significant and clinically meaningful…
